In Brief: Pharmacia & Upjohn
This article was originally published in The Tan Sheet
Executive Summary
Pharmacia & Upjohn: Purchases U.S. manufacturing rights to Nicotrol OTC smoking cessation patch from Cygnus Therapeutics, Cygnus announces March 6. J&J's McNeil subsidiary markets Nicotrol in the U.S. In 1993, Cygnus, which developed the Nicotrol nicotine patch, entered an exclusive agreement granting Pharmacia worldwide manufacturing rights to Nicotrol in return for royalties; the agreement was later amended so that Cygnus would manufacture and supply Nicotrol to the U.S. market through 1999. The agreement had an option clause allowing Pharmacia to purchase the rights prior to 1999...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning